Home » Roche’s New CEO Schwan Hopes Alnylam Will Be ‘Second Genentech’
Roche’s New CEO Schwan Hopes Alnylam Will Be ‘Second Genentech’
Roche Holdings AG’s new chief-executive-in-waiting, Severin Schwan hopes that new partner Alnylam Pharmaceuticals Inc will be Roche’s ‘second Genentech’ in the US, he said in an interview with Swiss weekly SonntagsZeitung.
CNN Money
Upcoming Events
-
07May
-
14May
-
30May